These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 30831)

  • 1. alpha-Chloralose and the central dopaminergic system.
    Massott M; Longo VG
    J Pharm Pharmacol; 1978 Oct; 30(10):667. PubMed ID: 30831
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment.
    Racagni G; Bruno F; Bugatti A; Parenti M; Apud JA; Santini V; Carenzi A; Groppetti A; Cattabeni F
    Adv Biochem Psychopharmacol; 1980; 24():45-51. PubMed ID: 7405672
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice.
    Cagiano R; De Salvia MA; Tattoli M; Lacomba C; Brunello N; Racagni G; Cuomo V
    Arch Toxicol Suppl; 1989; 13():375-7. PubMed ID: 2774963
    [No Abstract]   [Full Text] [Related]  

  • 4. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
    Piercey MF; Lum JT; Hoffmann WE; Carlsson A; Ljung E; Svensson K
    Brain Res; 1992 Aug; 588(2):217-22. PubMed ID: 1393576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dopaminergic potency of cocaine, procaine and lidocaine infused locally in the nucleus accumbens in vivo with calibration by capillary electrophoresis in vitro.
    Hernandez L; Guzman NA; Hoebel BG
    NIDA Res Monogr; 1990; 105():355-6. PubMed ID: 1678870
    [No Abstract]   [Full Text] [Related]  

  • 6. Nimodipine inhibits cocaine-induced dopamine release and motor stimulation.
    Pani L; Carboni S; Kusmin A; Gessa GL; Rossetti ZL
    Eur J Pharmacol; 1990 Feb; 176(2):245-6. PubMed ID: 2311670
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    J Pharm Pharmacol; 1980 Jan; 32(1):39-44. PubMed ID: 6102125
    [No Abstract]   [Full Text] [Related]  

  • 8. Species-dependent responsiveness to nonamphetamine central stimulants. Relationship between uptake and release of brain dopamine.
    McMillen BA; Shore PA
    Pharmacology; 1979; 19(5):261-6. PubMed ID: 43984
    [No Abstract]   [Full Text] [Related]  

  • 9. Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia.
    Opacka-Juffry J; Ahier RG; Cremer JE
    Synapse; 1991 Feb; 7(2):169-71. PubMed ID: 2011829
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopaminergic metabolism in various rat brain areas after L-dopa loading.
    el Gemayel G; Trouvin JH; Prioux-Guyonneau M; Jacquot C; Cohen Y
    J Pharm Pharmacol; 1986 Sep; 38(9):691-4. PubMed ID: 2877071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and schizophrenia.
    Westerink BH; Korf J
    Lancet; 1976 Oct; 2(7988):749. PubMed ID: 61434
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the dopaminergic system in the cataleptogenic action of bulbocapnine.
    Massotti M; Longo VG
    J Pharm Pharmacol; 1979 Oct; 31(10):691-5. PubMed ID: 41042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B; Micheletti G; Warter JM; Kempf E; Di Scala G
    Neurosci Lett; 1991 Jul; 128(2):177-81. PubMed ID: 1945038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain.
    Nielsen M; Braestrup C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):93-9. PubMed ID: 593431
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apomorphine-induced stereotyped biting in the tortoise in relation to dopaminergic mechanisms.
    Andersen H; Braestrup C; Randrup A
    Brain Behav Evol; 1975; 11(5-6):365-73. PubMed ID: 1238150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dopamine metabolism after small lesions in the midbrain of the rat.
    Westerink BH; van der Heyden JA; Korf J
    Life Sci; 1978 Mar; 22(9):749-56. PubMed ID: 642721
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
    Bekris S; Antoniou K; Daskas S; Papadopoulou-Daifoti Z
    Behav Brain Res; 2005 Jun; 161(1):45-59. PubMed ID: 15904709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical and behavioral studies on the mode of action of oxypertine.
    Moroji T; Okuyama T; Hagino Y; Sekiguchi R
    Arzneimittelforschung; 1986 May; 36(5):804-8. PubMed ID: 2873819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of methionine-enkephalin and (D-Ala2)methionine-enkephalin amide on the metabolism of dopamine and norephinephrine in rat brain:fact or artifact?
    Calderini G; Consolazione A; Garattini S; Algeri S
    Brain Res; 1978 May; 146(2):392-9. PubMed ID: 647397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.